Resultados de la búsqueda 271-280 of 15571 for Gynecological Care

1. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   ... care into the outpatient, secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient ...

2. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   ... care into the outpatient, secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Treatment options are then defined according to the disease burden strata. Treatment is allocated by randomisation. Patients may be allocated to one of ...

4. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   ... care into the outpatient, secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient ...

5. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   ... care into the outpatient, secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient ...

6. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   ... care into the outpatient, secondary prevention setting for the first 30 days after hospitalization. Finally, it will allow characterization of patient ...

7. Oncología (médica) - Ensayos clínicos

   Gynecologic Extramammary Paget's Disease ... care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. ... treatment plus blinatumomab.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Care in NSCLC patients with PD-L1 positive tumours and the combination of MEDI4736 plus tremelimumab (MEDI4736+treme) versus Standard of Care in NSCLC ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Gynecologic Extramammary Paget's Disease. Rochester, Minn. In addition to evaluating treatment ... care (SOC) chemotherapy regimens for the treatment of advanced ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...